Becton Dickinson and Company is a medical instruments & supplies business based in the US. Becton Dickinson and Company shares (BDX) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $224.00 – a decrease of 0.51% over the previous week. Becton Dickinson and Company employs 70,000 staff and has a trailing 12-month revenue of around $19.8 billion.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $224.00 |
|---|---|
| 52-week range | $217.86 - $246.89 |
| 50-day moving average | $235.15 |
| 200-day moving average | $235.88 |
| Wall St. target price | $281.10 |
| PE ratio | 37.7104 |
| Dividend yield | $3.76 (1.74%) |
| Earnings per share (TTM) | $5.94 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $225.45 from 2024-11-21
| 1 week (2024-11-15) | 0.13% |
|---|---|
| 1 month (2024-10-23) | -6.27% |
| 3 months (2024-08-22) | -4.19% |
| 6 months (2024-05-22) | -3.84% |
| 1 year (2023-11-22) | -4.79% |
|---|---|
| 2 years (2022-11-22) | -1.32% |
| 3 years (2021-11-22) | 228.9292 |
| 5 years (2019-11-22) | 227.1207 |
Valuing Becton Dickinson and Company stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Becton Dickinson and Company's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Becton Dickinson and Company's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 38x. In other words, Becton Dickinson and Company shares trade at around 38x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Becton Dickinson and Company's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.0334. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Becton Dickinson and Company's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Becton Dickinson and Company's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $5.1 billion.
The EBITDA is a measure of a Becton Dickinson and Company's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $19.8 billion |
|---|---|
| Operating margin TTM | 15.19% |
| Gross profit TTM | $8.8 billion |
| Return on assets TTM | 3.25% |
| Return on equity TTM | 5.63% |
| Profit margin | 7.13% |
| Book value | $89.50 |
| Market Capitalization | $64.7 billion |
TTM: trailing 12 months
Dividend payout ratio: 28.88% of net profits
Recently Becton Dickinson and Company has paid out, on average, around 0% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Becton Dickinson and Company shareholders could enjoy a 0% return on their shares, in the form of dividend payments. In Becton Dickinson and Company's case, that would currently equate to about $3.76 per share.
While Becton Dickinson and Company's payout ratio might seem fairly standard, it's worth remembering that Becton Dickinson and Company may be investing much of the rest of its net profits in future growth.
Becton Dickinson and Company's most recent dividend payout was on 30 December 2024. The latest dividend was paid out to all shareholders who bought their shares by 8 December 2024 (the "ex-dividend date").
Becton Dickinson and Company's shares were split on a 1025:1000 basis on 31 March 2022 . So if you had owned 1000 shares the day before before the split, the next day you'd have owned 1025 shares. This wouldn't directly have changed the overall worth of your Becton Dickinson and Company shares – just the quantity. However, indirectly, the new 2.4% lower share price could have impacted the market appetite for Becton Dickinson and Company shares which in turn could have impacted Becton Dickinson and Company's share price.
Over the last 12 months, Becton Dickinson and Company's shares have ranged in value from as little as $217.8568 up to $246.8876. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Becton Dickinson and Company's is 0.45. This would suggest that Becton Dickinson and Company's shares are less volatile than average (for this exchange).
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; and prefillable drug delivery systems. The BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey. .
Some of the best paper trading apps to practice stock trading with fake money include Interactive Brokers, eToro, Charles Schwab and more.
Want to buy and sell international stocks? Here are the top brokers to help you trade global markets.
These are the best discount brokers of 2024 according to Finder’s comprehensive review.
The best platforms to use for automatic investing include Wealthfront, SoFi, Schwab, Vanguard, Titan, Acorns and more. See our full list here.
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
5 Betterment robo-advisor alternatives to consider when building your portfolio.
What you need to know about investing in the leading indicator for the overall US stock market.
How do you gift stocks to loved ones? Learn the ins and outs of finding the right investments for them.
Check out the best-performing ETFs so far in 2024.
Acorns is a financial service that rounds up your purchases and turns the extra change into investments.